Abstract
We investigated the cytochrome P-450-dependent metabolism of 1,1-dichloroethylene (DCE) by human lung and liver microsomes and compared the results from analogous experiments in mice. Metabolites were identified by HPLC analysis of their glutathione conjugates and/or hydrolyzed products and were detected by using [14C]DCE. The role of human CYP2E1 in the metabolic reactions was examined by comparing p-nitrophenol hydroxylase activities with levels of metabolites formed and by using the CYP2E1-selective inhibitor diallyl sulfone. The major products formed in microsomal incubations containing NADPH were the DCE-epoxide-derived glutathione conjugates 2-(S-glutathionyl)acetyl glutathione and 2-S-glutathionyl acetate. Lower levels of the acetal of 2,2-dichloroacetaldehyde were also detected. In lung samples from eight patients, the amounts of epoxide-derived conjugates formed ranged from 15.6 ± 4.23 to 34.9 ± 12.75 pmol/mg protein/min. The levels in murine lung were higher at 40.0 ± 3.8 pmol/mg protein/min. In liver samples from five patients, conjugate levels ranged from 46.5 ± 8.3 to 240.0 ± 10.5 pmol/mg protein/min, whereas levels in murine liver were 83.0 ± 6.2 pmol/mg protein/min. Conjugate levels formed in human liver correlated with the relative levels of p-nitrophenol hydroxylase activity present, but this relationship was equivocal in human lung. Diallyl sulfone inhibited the formation of the glutathione conjugates (20–65%) in liver samples from all four patients, whereas only one of five human lung samples exhibited this inhibition (27%). These results demonstrated that the DCE-epoxide is a major metabolite formed by human microsomes and is mediated by CYP2E1 in liver and in some individuals in lung.
Footnotes
-
Send reprint requests to: Dr. Poh-Gek Forkert, Department of Anatomy and Cell Biology, Kingston, Ontario, Canada K7L 3N6. E-mailforkertp{at}post.queensu.ca
-
↵1 This research was supported by Grant MT-11706 from the Medical Research Council of Canada (to P.G.F.), Grant RO1-CA73220-01 from the U.S. National Cancer Institute (to P.G.F.), the Arizona Disease Control Research Commission (to J.B.U.), and National Institute of Environmental Health Sciences Center Grant P30-ES-06694 (to J.B.U).
- Abbreviations:
- [A]
- S-(2,2-dichloro-1-hydroxy)ethyl glutathione
- [B]
- 2-(S-glutathionyl) acetyl glutathione
- [C]
- 2-S-glutathionyl acetate
- [D]
- S-(2-chloroacetyl)-glutathione
- DASO2
- diallyl sulfone
- DCE
- 1,1-dichloroethylene
- GSH
- glutathione
- PNP
- p-nitrophenol
- Received September 23, 1998.
- Accepted December 3, 1998.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|